Top

Journal of Assisted Reproduction and Genetics

Published in:

01-02-2014 | Genetics

A comparative cytogenetic study of miscarriages after IVF and natural conception in women aged under and over 35 years

Authors: Anna A. Pendina, Olga A. Efimova, Olga G. Chiryaeva, Andrei V. Tikhonov, Lubov’ I. Petrova, Vera S. Dudkina, Natalia A. Sadik, Irina D. Fedorova, Ilona A. Galembo, Tatyana V. Kuznetzova, Alexander M. Gzgzyan, Vladislav S. Baranov

Published in: Journal of Assisted Reproduction and Genetics | Issue 2/2014

Abstract

Purpose

To compare the frequency and the spectrum of karyotype abnormality in the first trimester miscarriages in women aged under and over 35 years, who conceived naturally (NC) and who conceived through in vitro fertilization (IVF).

Methods

Comparative analysis of cytogenetic data obtained by karyotyping of miscarriages in patients who conceived naturally, and who conceived through IVF. Patients were subcategorized by their age: <35 years (NC, n = 173; IVF, n = 108) and ≥35 years (NC, n = 107; IVF, n = 111).

Results

A total of 499 miscarriage karyotypes was analyzed. The spectrum and the relative proportions of different cytogenetic categories in karyotypically abnormal miscarriages differed neither between the NC and IVF patients aged <35 years, nor between the NC and IVF patients aged ≥35 years. In the patients aged <35 years, the incidence of abnormal miscarriage karyotype was lower in the IVF group (37.04 % vs 62.43 %). In the patients aged ≥35 years, the incidence of miscarriages with cytogenetic pathology did not differ between the NC and the IVF group (75.70 % vs 58.56 %). The lowest frequency of karyotypically abnormal miscarriages (29.82 %) was detected in the young IVF-treated patients at <7 weeks of gestation.

Conclusions

IVF does not increase the risk of a pregnancy loss because of abnormal embryonic karyotype, nor does it increase the preponderance for any specific type of cytogenetic abnormality in both patients aged under and over 35 years. In young IVF-treated women early pregnancy loss is generally caused by non-cytogenetic factors. Identification of a cytogenetically normal spontaneous abortion is clinically significant and reinforces the importance of developing an appropriate diagnosis and treatment strategies for IVF patients in order to reduce the risk of euploid pregnancy loss.

Simpson JL, Bombard AT. Chromosomal abnormalities in spontaneous abortion: frequency, pathology and genetic counselling. In: Edmonds K, Bennett MJ, editors. Spontaneous abortion. London: Blackwell; 1987. p. 51–76.

Redline RW, Zaragoza M, Hassold T. Prevalence of developmental and inflammatory lesions in nonmolar first-trimester spontaneous abortions. Hum Pathol. 1999;30(1):93–100.PubMedCrossRef

Maher ER, Afnan M, Barratt CL. Epigenetic risks related to assisted reproductive technologies: epigenetics, imprinting, ART and icebergs? Hum Reprod. 2003;18(12):2508–11.PubMedCrossRef

Yamada H, Shimada S, Morikawa M, Iwabuchi K, Kishi R, Onoé K, et al. Divergence of natural killer cell receptor and related molecule in the decidua from sporadic miscarriage with normal chromosome karyotype. Mol Hum Reprod. 2005;11(6):451–7.PubMedCrossRef

Morales C, Sanchez A, Bruguera J, Margarit E, Borrell A, Borobio V, et al. Cytogenetic study of spontaneous abortions using semi-direct analysis of chorionic villi samples detects the broadest spectrum of chromosome abnormalities. Am J Med Genet A. 2008;146:66–70.CrossRef

Guerneri S, Bettio D, Simoni G, Brambati B, Lanzani A, Fraccaro M. Prevalence and distribution of chromosome abnormalities in a sample of first trimester internal abortions. Hum Reprod. 1987;2:735–9.PubMed

Nagaishi M, Yamamoto T, Iinuma K, Shimomura K, Berend SA, Knops J. Chromosome abnormalities identified in 347 spontaneous abortions collected in Japan. J Obstet Gynaecol Res. 2004;30:237–41.PubMedCrossRef

Yusuf RZ, Naeem R. Cytogenetic abnormalities in products of conception: a relationship revisited. Am J Reprod Immunol. 2004;52:88–96.PubMedCrossRef

Snijders RJ, Holzgreve W, Cuckle H, Nicolaides KH. Maternal age-specific risks for trisomies at 9-14 weeks’ gestation. Prenat Diagn. 1994;14(7):543–52.PubMedCrossRef

10.

Snijders RJ, Sebire NJ, Nicolaides KH. Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther. 1995;10(6):356–67.PubMedCrossRef

11.

Spandorfer SD, Davis OK, Barmat LI, Chung PH, Rosenwaks Z. Relationship between maternal age and aneuploidy in in vitro fertilization pregnancy loss. Fertil Steril. 2004;81(5):1265–9.PubMedCrossRef

12.

Grande M, Borrell A, Garcia-Posada R, Borobio V, Muñoz M, Creus M, et al. The effect of maternal age on chromosomal anomaly rate and spectrum in recurrent miscarriage. Hum Reprod. 2012;27(10):3109–17.PubMedCrossRef

13.

Bettio D, Venci A, Levi Setti PE. Chromosomal abnormalities in miscarriages after different assisted reproduction procedures. Placenta. 2008;29(Suppl B):S126–S128. doi:10.1016/j.placenta.2008.08.015.

14.

Kim JW, Lee WS, Yoon WK, Lee WS, Cho JH, Kim YS, et al. Chromosomal abnormalities in spontaneous abortion after assisted reproductive treatment. BMC Med Genet. 2010;11:153.PubMedCentralPubMedCrossRef

15.

Bingol B, Abike F, Gedikbasi A, Tapisiz OL, Gunenc Z. Comparison of chromosomal abnormality rates in ICSI for non-male factor and spontaneous conception. J Assist Reprod Genet. 2012;29(1):25–30.PubMedCrossRef

16.

Werner M, Reh A, Grifo J, Perle MA. Characteristics of chromosomal abnormalities diagnosed after spontaneous abortions in an infertile population. J Assist Reprod Genet. 2012;29(8):817–20.PubMedCrossRef

17.

Baranov VS, Lebedev VM, Poleev AV, Mikhaĭlova EP, Rybalko AV, Shved NV. Fast direct method of obtaining metaphase and prometaphase chromosomes from chorion biopsy cells and human embryos during the lst trimester of pregnancy. Biull Eksp Biol Med. 1990;110(8):196–8.PubMed

18.

Pflueger SMV. The cytogenetics of spontaneous abortion. In: Gersen SL, Keagle MB, editors. The principles of clinical cytogenetics. New York: Springer; 2013. p. 275–92.

19.

Hassold T, Hunt P. Maternal age and chromosomally abnormal pregnancies: what we know and what we wish we knew. Curr Opin Pediatr. 2009;21(6):703–8.PubMedCentralPubMedCrossRef

20.

Martínez MC, Méndez C, Ferro J, Nicolás M, Serra V, Landeras J. Cytogenetic analysis of early nonviable pregnancies after assisted reproduction treatment. Fertil Steril. 2010;93(1):28992.CrossRef

21.

Boué A, Boué J, Gropp A. Cytogenetics of pregnancy wastage. Adv Hum Genet. 1985;14:1–57.PubMed

22.

Clifford K, Flanagan AM, Regan L. Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod. 1999;14(11):2727–30.PubMedCrossRef

23.

Quenby S, Bates M, Doig T, Brewster J, Lewis-Jones DI, Johnson PM, et al. Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Hum Reprod. 1999;14(9):2386–91.PubMedCrossRef

24.

Tuckerman E, Laird SM, Prakash A, Li TC. Prognostic value of the measurement of uterine natural killer cells in the endometrium of women with recurrent miscarriage. Hum Reprod. 2007;22(8):2208–13.PubMedCrossRef

25.

Li TC, Spuijbroek MD, Tuckerman E, Anstie B, Loxley M, Laird S. Endocrinological and endometrial factors in recurrent miscarriage. BJOG. 2000;107(12):1471–9.PubMedCrossRef

26.

Tuckerman E, Laird SM, Stewart R, Wells M, Li TC. Markers of endometrial function in women with unexplained recurrent pregnancy loss: a comparison between morphologically normal and retarded endometrium. Hum Reprod. 2004;19(1):196–205.PubMed

27.

Bellver J, Soares SR, Alvarez C, Muñoz E, Ramírez A, Rubio C, et al. The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion. Hum Reprod. 2008;23(2):278–84.PubMedCrossRef

28.

Kroon B, Harrison K, Martin N, Wong B, Yazdani A. Miscarriage karyotype and its relationship with maternal body mass index, age, and mode of conception. Fertil Steril. 2011;95(5):1827–9.PubMedCrossRef

29.

Fulka H, Mrazek M, Tepla O, Fulka Jr J. DNA methylation pattern in human zygotes and developing embryos. Reproduction. 2004;128(6):703–8.PubMedCrossRef

30.

Baranov VS, Pendina AA, Kuznetsova TV, Efimova OA, Fedorova ID, Leont’eva OA, et al. Peculiarities of metaphase chromosome methylation pattern in preimplantation human embryos. Tsitologiia. 2005;47(8):723–30. Russian.PubMed

31.

Pendina AA, Efimova OA, Kaminskaia AN, Kuznetsova TV, Baranov VS. Immunocytochemical analysis of human metaphase chromosome methylation status. Tsitologiia. 2005;47(8):731–7. Russian.PubMed

32.

Pendina AA, Efimova OA, Fedorova ID, Leont’eva OA, Shilnikova EM, Lezhnina JG, et al. DNA methylation patterns of metaphase chromosomes in human preimplantation embryos. Cytogenet Genome Res. 2011;132(1–2):1–7.PubMedCrossRef

33.

Sazhenova EA, Skryabin NA, Sukhanova NN, Lebedev IN. Multilocus epimutations of imprintome in the pathology of human embryo development. Mol Biol. 2012;46(2):183–91.CrossRef

34.

Zheng HY, Tang Y, Niu J, Li P, Ye DS, Chen X, et al. Aberrant DNA methylation of imprinted loci in human spontaneous abortions after assisted reproduction techniques and natural conception. Hum Reprod. 2013;28(1):265–73.PubMedCrossRef

35.

Lidegaard O, Pinborg A, Andersen AN. Imprinting diseases and IVF: Danish National IVF cohort study. Hum Reprod. 2005;20(4):950–4.PubMedCrossRef

36.

Lidegaard Ø, Pinborg A, Andersen AN. Imprinting disorders after assisted reproductive technologies. Curr Opin Obstet Gynecol. 2006;18(3):293–6.PubMedCrossRef

37.

Grace KS, Sinclair KD. Assisted reproductive technology, epigenetics, and long-term health: a developmental time bomb still ticking. Semin Reprod Med. 2009;27(5):409–16.PubMedCrossRef

38.

Nelissen EC, Dumoulin JC, Daunay A, Evers JL, Tost J, van Montfoort AP. Placentas from pregnancies conceived by IVF/ICSI have a reduced DNA methylation level at the H19 and MEST differentially methylated regions. Hum Reprod. 2013;28(4):1117–26.PubMedCrossRef

Title: A comparative cytogenetic study of miscarriages after IVF and natural conception in women aged under and over 35 years
Authors: Anna A. Pendina
Olga A. Efimova
Olga G. Chiryaeva
Andrei V. Tikhonov
Lubov’ I. Petrova
Vera S. Dudkina
Natalia A. Sadik
Irina D. Fedorova
Ilona A. Galembo
Tatyana V. Kuznetzova
Alexander M. Gzgzyan
Vladislav S. Baranov
Publication date: 01-02-2014
Publisher: Springer US
Published in: Journal of Assisted Reproduction and Genetics / Issue 2/2014
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI: https://doi.org/10.1007/s10815-013-0148-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A comparative cytogenetic study of miscarriages after IVF and natural conception in women aged under and over 35 years

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2014

Relationship between HLA-G polymorphism and susceptibility to recurrent miscarriage: A meta-analysis of non-family-based studies

Are zona pellucida genes involved in recurrent oocyte lysis observed during in vitro fertilization?

Quality of embryos transferred and progesterone levels are the most important predictors of live birth after fresh embryo transfer: a retrospective cohort study

A new treatment to avoid severe ovarian hyperstimulation utilizing insights from in vitro maturation therapy

A randomized controlled trial comparing two vitrification methods versus slow-freezing for cryopreservation of human cleavage stage embryos

Ovarian sensitivity index is a better measure of ovarian responsiveness to gonadotrophin stimulation than the number of oocytes during in-vitro fertilization treatment